[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum

C44H34N4Pt — CID 162500086

IUPAC[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum
SMILESCc1ccnc(-c2cccc(N(c3cccc(-n4c(=[Pt])n(C)c5ccccc54)c3)c3c(-c4ccccc4)cccc3-c3ccccc3)c2)c1
InChIInChI=1S/C44H34N4.Pt/c1-32-26-27-45-41(28-32)35-18-11-20-37(29-35)48(38-21-12-19-36(30-38)47-31-46(2)42-24-9-10-25-43(42)47)44-39(33-14-5-3-6-15-33)22-13-23-40(44)34-16-7-4-8-17-34;/h3-30H,1-2H3;
InChIKeyUPBYYGHUCFUDRJ-UHFFFAOYSA-N
MW813.86 g/mol
LogP11.22
Rot. Bonds7

About [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum

[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum (PubChem CID 162500086) has the molecular formula C44H34N4Pt and a molecular weight of 813.86 g/mol. Its IUPAC name is [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum
PubChem CID162500086
Molecular FormulaC44H34N4Pt
Molecular Weight813.86 g/mol
Exact Mass813.24
IUPAC Name[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum
SMILESCc1ccnc(-c2cccc(N(c3cccc(-n4c(=[Pt])n(C)c5ccccc54)c3)c3c(-c4ccccc4)cccc3-c3ccccc3)c2)c1
InChIInChI=1S/C44H34N4.Pt/c1-32-26-27-45-41(28-32)35-18-11-20-37(29-35)48(38-21-12-19-36(30-38)47-31-46(2)42-24-9-10-25-43(42)47)44-39(33-14-5-3-6-15-33)22-13-23-40(44)34-16-7-4-8-17-34;/h3-30H,1-2H3;
InChIKeyUPBYYGHUCFUDRJ-UHFFFAOYSA-N
XLogP11.22
TPSA25.99 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500813.86
LogP ≤ 511.22
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum (CID 162500086) is [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum is Cc1ccnc(-c2cccc(N(c3cccc(-n4c(=[Pt])n(C)c5ccccc54)c3)c3c(-c4ccccc4)cccc3-c3ccccc3)c2)c1.
What is the InChIKey of [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum?
The InChIKey is UPBYYGHUCFUDRJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H34N4.Pt/c1-32-26-27-45-41(28-32)35-18-11-20-37(29-35)48(38-21-12-19-36(30-38)47-31-46(2)42-24-9-10-25-43(42)47)44-39(33-14-5-3-6-15-33)22-13-23-40(44)34-16-7-4-8-17-34;/h3-30H,1-2H3;.
What are the key properties of [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum?
[1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum has a molecular weight of 813.86 g/mol, XLogP of 11.22, 7 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[N-(2,6-diphenylphenyl)-3-(4-methyl-2-pyridinyl)anilino]phenyl]-3-methylbenzimidazol-2-ylidene]platinum is sourced from PubChem (CID 162500086), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).